and sporadic disease. Neurosurgery. 2001; 48( 1):55-62; discussion
45. Emery E, Hurth M, Lacroix-Jousselin C, David P, Richard S.
Intraspinal hemangioblastoma. Apropos of a recent series of 20
cases. Neurochirurgie. 1994; 40( 3):165-73.
46. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural
history of hemangioblastomas of the central nervous system
in patients with von Hippel-Lindau disease. J Neurosurg.
47. Biondi A, Ricciardi GK, Faillot T, Capelle L, Effenterre RV, Chiras
J. Hemangioblastomas of the lower spinal region: report of four
cases with preoperative embolization and review of the literature.
AJNR Am J Neuroradiol. 2005; 26( 4):936-45.
48. Takeuchi S, Tanaka R, Fujii Y, Abe H, Ito Y. Surgical treatment of
hemangioblastomas with presurgical endovascular embolization.
Neurol Med Chir ( Tokyo). 2001; 41( 5):246-51; discussion 251-252.
49. Jones K, Meyers P, Gobin P, Liu AH. Embolization of spinal tumors.
Operative Techniques in Neurosurgery. 2003; 6( 3):156-162.
AL Brook: nothing to disclose.
D Altschul: nothing to disclose.
JE Tepper: unavailable at press time.
RV Rotman: unavailable at press time.
A Kobets: unavailable at press time.
T Miller: nothing to disclose.
Direct or indirect remuneration: royalties, stock ownership, private
investments, consulting, speaking and/or teaching arrangements, trips/travel.
Position held in a company: board of directors, scientific advisory board, other
office. Support from sponsors: endowments, research–investigator salary,
research–staff and/or materials, grants, fellowship support. Other
Degree of support:
Level A. $100 to $1000 Level F. $100,001 to $500,000
Level B. $1,001 to $10,000 Level G. $500,001 to $1M
Level C. $10,001 to $25,000 Level H. $1,000,001 to $2.5M
Level D. $25,001 to $50,000 Level I. greater than $2.5M
Level E. $50,001 to $100,000